Real-time enrollment status for this recurrent glioblastoma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 9:24 PM UTC
| NCT Number | NCT07209241 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Glioblastoma |
| Phase | PHASE1 |
| Target Enrollment | 12 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Pennsylvania |
| Last Updated on CT.gov | May 11, 2026 (May 11, 2026) |
As of July 17, 2026: Clinical trial NCT07209241 is currently recruiting participants. This phase1 study for recurrent glioblastoma is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Pennsylvania. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07209241 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07209241 was last updated May 11, 2026 (May 11, 2026). HelloStudys verifies this status automatically.